Рязанский медицинский институт им.акад.И.П.Павлова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рязанский медицинский институт им.акад.И.П.ПавловаfiledCriticalРязанский медицинский институт им.акад.И.П.Павлова
Priority to SU2652522/04ApriorityCriticalpatent/SU694037A1/en
Application grantedgrantedCritical
Publication of SU694037A1publicationCriticalpatent/SU694037A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members
(AREA)
Abstract
2-(3,4-Диметоксибензилиденгидразино)-4-фенил-5-n-[N-(5-этил-1,3,4, -тиадиазолил-2)сульфамоил]фенилазоселеназол формулыобладающий активностью в отношении грамположительных бактерий.2- (3,4-Dimethoxybenzylidene hydrazino) -4-phenyl-5-n- [N- (5-ethyl-1,3,4, -thiadiazolyl-2) sulfamoyl] phenylaselenazole has a formula with activity against gram-positive bacteria.